Nektar Therapeutics PE Ratio 2006-2020 | NKTR

Current and historical p/e ratio for Nektar Therapeutics (NKTR) from 2006 to 2020. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. Nektar Therapeutics PE ratio as of July 09, 2020 is 0.00.
Nektar Therapeutics PE Ratio Historical Data
Date Stock Price TTM Net EPS PE Ratio
2020-07-09 24.43 0.00
2020-03-31 17.85 $-2.61 0.00
2019-12-31 21.59 $-2.51 0.00
2019-09-30 18.22 $-2.44 0.00
2019-06-30 35.58 $-2.44 0.00
2019-03-31 33.60 $3.52 9.55
2018-12-31 32.87 $3.60 9.13
2018-09-30 60.96 $3.96 15.39
2018-06-30 48.83 $4.89 9.99
2018-03-31 106.26 $-0.83 0.00
2017-12-31 59.72 $-0.65 0.00
2017-09-30 24.00 $-0.72 0.00
2017-06-30 19.55 $-1.41 0.00
2017-03-31 23.47 $-1.38 0.00
2016-12-31 12.27 $-1.10 0.00
2016-09-30 17.18 $-1.22 0.00
2016-06-30 14.23 $-0.96 0.00
2016-03-31 13.75 $-1.00 0.00
2015-12-31 16.85 $-0.61 0.00
2015-09-30 10.96 $-0.56 0.00
2015-06-30 12.51 $0.03 417.00
2015-03-31 11.00 $0.17 64.71
2014-12-31 15.50 $-0.45 0.00
2014-09-30 12.07 $-0.51 0.00
2014-06-30 12.82 $-1.18 0.00
2014-03-31 12.12 $-1.29 0.00
2013-12-31 11.35 $-1.40 0.00
2013-09-30 10.45 $-1.45 0.00
2013-06-30 11.55 $-1.69 0.00
2013-03-31 11.00 $-1.62 0.00
2012-12-31 7.41 $-1.50 0.00
2012-09-30 10.68 $-1.37 0.00
2012-06-30 8.07 $-1.20 0.00
2012-03-31 7.92 $-1.22 0.00
2011-12-31 5.60 $-1.19 0.00
2011-09-30 4.85 $-1.10 0.00
2011-06-30 7.27 $-0.98 0.00
2011-03-31 9.47 $-0.67 0.00
2010-12-31 12.85 $-0.41 0.00
2010-09-30 14.77 $-0.25 0.00
2010-06-30 12.10 $-0.49 0.00
2010-03-31 15.21 $-0.83 0.00
2009-12-31 9.32 $-1.10 0.00
2009-09-30 9.74 $-0.19 0.00
2009-06-30 6.48 $-0.26 0.00
2009-03-31 5.39 $-0.27 0.00
2008-12-31 5.56 $-0.37 0.00
2008-09-30 3.59 $-0.78 0.00
2008-06-30 3.35 $-0.58 0.00
2008-03-31 6.94 $-0.52 0.00
2007-12-31 6.71 $-0.36 0.00
2007-09-30 8.83 $-1.21 0.00
2007-06-30 9.49 $-1.23 0.00
2007-03-31 13.06 $-1.63 0.00
2006-12-31 15.21 $-1.73 0.00
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $4.412B $0.115B
Nektar Therapeutics is a clinical-stage biopharmaceutical company developing a pipeline of drug candidates that utilize its PEGylation and polymer conjugate technology platforms, which are designed to meet unmet medical needs and improve the benefits of drugs for patients. Its product pipeline consists of drug candidates across a number of therapeutic areas, including oncology, pain. In the area of pain, Nektar has a worldwide license agreement with AstraZeneca for NKTR-118, an investigational drug candidate, being evaluated in Phase 3 clinical studies as a once-daily, oral tablet for the treatment of opioid-induced constipation. The agreement also includes NKTR-119, an earlier stage development program that is a co-formulation of NKTR-118 and an opioid. Also in the area of pain, NKTR-181, the company's wholly-owned novel mu-opioid analgesic molecule, is being evaluated in Phase 1 clinical studies. Nektar Therapeutics is headquartered in San Francisco, California.
Stock Name Country Market Cap PE Ratio
Zoetis (ZTS) United States $65.927B 37.42
Takeda Pharmaceutical (TAK) Japan $55.110B 9.66
Astellas Pharma (ALPMY) Japan $29.863B 15.13
Eisai (ESALY) Japan $24.541B 21.27
UCB SA (UCBJF) Belgium $23.292B 0.00
Merck (MKGAF) Germany $15.852B 20.79
Grifols, S.A (GRFS) Spain $12.782B 15.89
Neurocrine Biosciences (NBIX) United States $12.083B 55.84
Catalent (CTLT) United States $11.806B 45.64
Recordati Industria Chimica E Farmaceutica S.P.A (RCDTF) Italy $9.945B 0.00
Ono Pharmaceutical (OPHLF) Japan $9.254B 0.00
Ionis Pharmaceuticals (IONS) United States $8.486B 45.12
IPSEN SA ADR (IPSEY) France $7.290B 0.00
Orion OYJ (ORINY) Finland $6.936B 31.08
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $6.664B 0.00
Jazz Pharmaceuticals (JAZZ) Ireland $5.952B 9.53
United Therapeutics (UTHR) United States $5.184B 9.82
STADA ARZNEIMI (STDAF) Germany $4.916B 0.00
Arrowhead Pharmaceuticals (ARWR) United States $4.605B 502.78
Evotec AG (EVTCY) Germany $4.090B 110.22
Hypermarcas (HYPMY) Brazil $3.857B 11.73
ChemoCentryx (CCXI) United States $3.816B 0.00
PTC Therapeutics (PTCT) United States $3.737B 0.00
FibroGen (FGEN) United States $3.734B 0.00
Taro Pharmaceutical Industries (TARO) Israel $2.518B 10.35
Pacira BioSciences (PCRX) United States $2.382B 48.74
Sage Therapeutics (SAGE) United States $2.305B 0.00
Cronos Group (CRON) Canada $2.159B 61.90
Corcept Therapeutics (CORT) United States $1.930B 19.14
Xencor (XNCR) United States $1.878B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.759B 0.00
USANA Health Sciences (USNA) United States $1.737B 17.81
Akebia Therapeutics (AKBA) United States $1.697B 0.00
Indivior (INVVY) United States $1.604B 19.91
Ironwood Pharmaceuticals (IRWD) United States $1.592B 12.18
Zogenix (ZGNX) United States $1.565B 0.00
Esperion Therapeutics (ESPR) United States $1.456B 0.00
Karyopharm Therapeutics (KPTI) United States $1.424B 0.00
Heron Therapeutics (HRTX) United States $1.399B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $1.350B 14.55
Theravance Biopharma (TBPH) Cayman Islands $1.335B 0.00
CLINIGEN GP (CLIGF) United Kingdom $1.250B 0.00
Translate Bio (TBIO) United States $1.107B 0.00
Enanta Pharmaceuticals (ENTA) United States $1.007B 44.93
BioCryst Pharmaceuticals (BCRX) United States $0.958B 0.00
Tilray (TLRY) Canada $0.946B 0.00
ImmunoGen (IMGN) United States $0.814B 0.00
Endo (ENDP) Ireland $0.783B 1.21
Molecular Templates (MTEM) United States $0.633B 0.00
Ardelyx (ARDX) United States $0.627B 0.00
Aerie Pharmaceuticals (AERI) United States $0.623B 0.00
Trillium Therapeutics (TRIL) Canada $0.622B 0.00
VAXART, INC (VXRT) United States $0.605B 0.00
Radius Health (RDUS) United States $0.603B 0.00
Collegium Pharmaceutical (COLL) United States $0.587B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.576B 0.00
Crinetics Pharmaceuticals (CRNX) United States $0.539B 0.00
Catalyst Pharmaceuticals (CPRX) United States $0.525B 12.70
Innate Pharma SA (IPHYF) France $0.497B 0.00
BioSpecifics Technologies Corp (BSTC) United States $0.485B 18.92
Flexion Therapeutics (FLXN) United States $0.482B 0.00
Siga Technologies (SIGA) United States $0.455B 0.00
DURECT (DRRX) United States $0.433B 0.00
TherapeuticsMD (TXMD) United States $0.429B 0.00
Harpoon Therapeutics (HARP) United States $0.417B 0.00
Ocular Therapeutix (OCUL) United States $0.401B 0.00
Spectrum Pharmaceuticals (SPPI) United States $0.395B 0.00
Organogenesis Holdings (ORGO) United States $0.376B 0.00
Calithera Biosciences (CALA) United States $0.371B 0.00
MEI Pharma (MEIP) United States $0.361B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.330B 0.00
Concert Pharmaceuticals (CNCE) United States $0.313B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $0.285B 0.00
PROFOUND MEDICL (PROF) Canada $0.285B 0.00
Altimmune (ALT) United States $0.264B 0.00
Lannett Co Inc (LCI) United States $0.258B 5.65
Oasmia Pharmaceutical AB (OASMY) Sweden $0.257B 0.00
Redhill Biopharma (RDHL) Israel $0.246B 0.00
CASI Pharmaceuticals (CASI) United States $0.242B 0.00
Taiwan Liposome (TLC) Taiwan $0.234B 0.00
Jounce Therapeutics (JNCE) United States $0.217B 5.17
KalVista Pharmaceuticals (KALV) United States $0.210B 0.00
Rafael Holdings (RFL) United States $0.202B 0.00
OptiNose (OPTN) United States $0.195B 0.00
IMV INC (IMV) Canada $0.183B 0.00
Nivalis Therapeutics (ALPN) United States $0.179B 0.00
Nature's Sunshine Products (NATR) United States $0.174B 22.95
Aquestive Therapeutics (AQST) United States $0.155B 0.00
Matinas Biopharma Holdings (MTNB) United States $0.146B 0.00
Kitov Pharmaceuticals Holdings (KTOV) Israel $0.142B 0.00
La Jolla Pharmaceutical (LJPC) United States $0.123B 0.00
Champions Oncology (CSBR) United States $0.117B 0.00
Otonomy (OTIC) United States $0.110B 0.00
Summit Therapeutics (SMMT) United Kingdom $0.106B 0.00
CTI BioPharma (CTIC) United States $0.105B 0.00
Recro Pharma (REPH) United States $0.103B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.100B 0.00
Aptorum Group (APM) Hong Kong, SAR China $0.100B 0.00
Xeris Pharmaceuticals (XERS) United States $0.099B 0.00
MediWound (MDWD) Israel $0.098B 0.00
Onconova Therapeutics (ONTX) United States $0.097B 0.00
ALLERGY THERAPT (AGYTF) United Kingdom $0.095B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.092B 0.00
AcelRx Pharmaceuticals (ACRX) United States $0.089B 0.00
Hemispherx BioPharma (AIM) United States $0.085B 0.00
Sundial Growers (SNDL) Canada $0.084B 0.00
Biomerica (BMRA) United States $0.082B 0.00
Heat Biologics (HTBX) United States $0.075B 0.00
Aclaris Therapeutics (ACRS) United States $0.073B 0.00
SCYNEXIS (SCYX) United States $0.071B 0.00
ASSERTIO THERAPEUTICS, INC (ASRT) United States $0.065B 0.00
Lipocine (LPCN) United States $0.065B 0.00
Infinity Pharmaceuticals (INFI) United States $0.060B 0.00
CV Sciences (CVSI) United States $0.057B 0.00
RENEURON GP (RNUGF) United Kingdom $0.057B 0.00
Addex Therapeutics (ADXN) Switzerland $0.050B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.050B 29.82
PolarityTE (PTE) United States $0.048B 0.00
Natural Alternatives (NAII) United States $0.045B 0.00
Forward Pharma (FWP) Denmark $0.043B 0.00
IsoRay (ISR) United States $0.043B 0.00
Bellicum Pharmaceuticals (BLCM) United States $0.041B 0.00
Mannatechorporated (MTEX) United States $0.041B 7.76
Opiant Pharmaceuticals (OPNT) United States $0.040B 85.64
GTx (ONCT) United States $0.040B 0.00
Novan (NOVN) United States $0.039B 0.00
Adamis Pharmaceuticals (ADMP) United States $0.038B 0.00
Entasis Therapeutics Holdings (ETTX) United States $0.037B 0.00
Neos Therapeutics (NEOS) United States $0.035B 0.00
NovaBay Pharmaceuticals (NBY) United States $0.034B 0.00
AgeX Therapeutics (AGE) United States $0.034B 0.00
Jaguar Animal Health (JAGX) United States $0.033B 0.00
ElectroCore (ECOR) United States $0.032B 0.00
Dipexium Pharmaceuticals (PLXP) United States $0.027B 0.00
Eyegate Pharmaceuticals (EYEG) United States $0.024B 0.00
India Globalization Capital (IGC) United States $0.022B 0.00
Iterum Therapeutics (ITRM) Ireland $0.021B 0.00
Flex Pharma (SLRX) United States $0.020B 0.00
Bio-Path Holdings (BPTH) United States $0.019B 0.00
Tetraphase Pharmaceuticals (TTPH) United States $0.018B 0.00
Regulus Therapeutics (RGLS) United States $0.018B 0.00
ProPhase Labs (PRPH) United States $0.017B 0.00
Can-Fite Biopharma (CANF) Israel $0.016B 0.00
China SXT Pharmaceuticals (SXTC) China $0.015B 0.00
Cyanotech (CYAN) United States $0.014B 32.71
Shineco (TYHT) China $0.014B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.012B 0.00
Cytori Therapeutics Inc (PSTV) United States $0.010B 0.00
RXi Pharmaceuticals (PHIO) United States $0.010B 0.00
HANCOCK JAFFE (HJLI) United States $0.010B 0.00
Midatech Pharma (MTP) United Kingdom $0.009B 0.00
Vical (BBI) United States $0.009B 0.00
Xenetic Biosciences (XBIO) United States $0.007B 0.00
CannTrust Holdings (CTST) Canada $0.000B 0.00